ACON

Aclarion, Inc. Common Stock

3.23

USD

ACON Earnings Reports

Positive Surprise Ratio

ACON beat 6 of 12 last estimates.

50%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q4 25 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Aclarion, Inc. Common Stock earnings per share and revenue

On Mar 18, 2026, ACON reported earnings of -2.54 USD per share (EPS) for Q4 25, beating the estimate of -3.67 USD, resulting in a 30.83% surprise. Revenue reached 18.00 thousand, compared to an expected 20.40 thousand, with a -11.76% difference. The market reacted with a -1.81% price change (close before vs. close after earnings).

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

IceCure Medical Ltd. Ordinary Shares

Report Date

Mar 17, 2026 For Q4 25

Estimate

-$0.04

Actual

-$0.07

Surprise

-52.51%

Lifeward Ltd. Ordinary Shares

Report Date

Mar 18, 2026 For Q4 25

Estimate

-$1.10

Actual

-$3.60

Surprise

-226.80%

SeaStar Medical Holding Corporation Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$1.07

Actual

-$0.80

Surprise

+25.28%

Healthy Choice Wellness Corp.

Report Date

Mar 16, 2026 For Q4 25

Estimate

-$0.05

Actual

-$0.05

Surprise

+1.96%

HealthEquity, Inc

Report Date

Mar 17, 2026 For Q4 26

Estimate

$0.90

Actual

$0.95

Surprise

+4.51%

The Oncology Institute, Inc. Common Stock

Report Date

Mar 12, 2026 For Q4 25

Estimate

-$0.09

Actual

-$0.06

Surprise

+33.99%

The Beauty Health Company Class A Common Stock

Report Date

Mar 12, 2026 For Q4 25

Estimate

-$0.05

Actual

-$0.06

Surprise

-14.29%

Sera Prognostics, Inc. Class A Common Stock

Report Date

Mar 18, 2026 For Q4 25

Estimate

-$0.19

Actual

-$0.16

Surprise

+17.44%

DocGo Inc. Common Stock

Report Date

Mar 16, 2026 For Q4 25

Estimate

-$0.13

Actual

-$1.37

Surprise

-920.10%

FAQ

What were Aclarion, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Aclarion, Inc. Common Stock reported EPS of -$2.54, beating estimates by 30.83%, and revenue of $18.00K, -11.76% below expectations.

How did the market react to Aclarion, Inc. Common Stock's Q4 2025 earnings?

The stock price moved down -1.81%, changed from $3.32 before the earnings release to $3.26 the day after.

When is Aclarion, Inc. Common Stock expected to report next?

The next earning report is scheduled for --.

What are the forecasts for Aclarion, Inc. Common Stock's next earnings report?

Based on -- analysts, Aclarion, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.